YISHENGTANG
Key words:
Crosslinked starch hemostatic material
Absorbable hemostatic materials from pure plants Class III patented products
Key words:
Shuchong Ning is prepared with carboxymethyl chitosan (prepared by imported Alaska snow crab through advanced biological technology) as the main ingredient, supplemented by physiological balance solution, with a concentration of 5mg/ml, colorless, transparent and viscous liquid; The product has no stimulation, sensitization, heat source and cytotoxicity
Key words:
Shu Yining is a three class medical device independently developed by Shijiazhuang Yishengtang Medical Supplies Co., Ltd. It is a colorless transparent viscous liquid (colorless or light yellow transparent gel) with carboxymethyl chitosan (imported Alaska snow crab, prepared by advanced biological process) as the main component, and prepared with physiological balance solution with a concentration of 25mg/ml.
Key words:
Microporous polysaccharide hemostatic powder
Microporous polysaccharide hemostatic powder is a natural polysaccharide with microporous structure, which is copolymerized from starch polysaccharides and is prepared from purified plant starch.
Key words:
Invitation | 89th China International Medical Equipment Expo
Shijiazhuang Yishengtang Medical Supplies Co., Ltd. sincerely invites you to attend the 89th China International Medical Equipment Expo.
Key words:
At the recently held "Second Taishan Pharmaceutical Forum", the National Federation of Industry and Commerce Pharmaceutical Industry Chamber awarded our company's chairman, Mr. Liu Shengjun, the title of "Person of the Year for Promoting High-Quality Development of the Pharmaceutical and Health Industry for 2022-2023."
Key words:
Dear partners, suppliers, and citizens: We, Shijiazhuang Yishengtang Medical Supplies Co., Ltd., hereby solemnly promise to always adhere to the concepts of environmental protection and sustainable development. In order to better fulfill our corporate social responsibility and improve the management level of hazardous waste, we have specially formulated and publicly announced the "Hazardous Waste Management Plan."
Key words:
In order to deepen the exchange of experiences in the quality and safety management of medical devices, promote the regulatory policies for medical devices, further standardize the production, operation, and use of medical devices, enhance the professional skills and regulatory capabilities of regulatory personnel, and promote the healthy development of the medical device industry, the "Quality and Safety Experience Exchange and Regulatory Law Promotion Activity for the Production, Operation, and Use of Medical Devices" was successfully held at the Provincial Senior University, organized by the Hebei Provincial Drug Supervision Administration and hosted by the Hebei Provincial Medical Device Industry Association, according to the activity arrangement for the 2023 Provincial Medical Device Safety Promotion Week.
Key words:
The approval of this certification is a comprehensive affirmation of Shijiazhuang Yishengtang Company's focus, innovation capability, core competitiveness, and quality management in the high-end biomedical materials niche market.
Key words:
The four seasons cycle and the sun and moon are long, flowers bloom and fall, fragrant year after year. In the beautiful moment of April, we grandly hold the 2023 first quarter marketing conference of Shijiazhuang Yishengtang Medical Supplies Co., Ltd.; under the impact of a complex and changing internal and external environment, the collective staff, led by Chairman Liu Shengjun, overcome difficulties, uphold their beliefs, go against the trend, and innovate. Together with all colleagues, we strive to promote the deepening of organizational reform at Yishengtang Company, fully embark on a new journey of national development, achieve new breakthroughs in various tasks, and further enhance the company's overall strength.
Key words:
Latest Products
Latest News
YISHENGTANG MEDICAL PRODUCT
We hope to continuously and rapidly launch forward-looking and market competitive medical products by building a sound R&D competitiveness;
